1. Home
  2. KWR vs AGIO Comparison

KWR vs AGIO Comparison

Compare KWR & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KWR

Quaker Houghton

N/A

Current Price

$147.48

Market Cap

2.7B

Sector

Industrials

ML Signal

N/A

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

N/A

Current Price

$27.58

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KWR
AGIO
Founded
1918
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
KWR
AGIO
Price
$147.48
$27.58
Analyst Decision
Strong Buy
Buy
Analyst Count
7
10
Target Price
★ $192.00
$45.67
AVG Volume (30 Days)
112.0K
★ 957.9K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 1.40%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 4.40
N/A
Revenue
★ $1,888,634,000.00
$43,011,000.00
Revenue This Year
$8.96
$242.92
Revenue Next Year
$4.54
$88.47
P/E Ratio
$34.35
★ N/A
Revenue Growth
★ 2.66
N/A
52 Week Low
$112.18
$24.16
52 Week High
$183.01
$44.09

Technical Indicators

Market Signals
Indicator
KWR
AGIO
Relative Strength Index (RSI) 41.97 34.56
Support Level $145.76 $27.14
Resistance Level $148.40 $29.78
Average True Range (ATR) 5.24 1.68
MACD -0.25 -0.40
Stochastic Oscillator 18.13 0.35

Price Performance

Historical Comparison
KWR
AGIO

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: